[Anti-centromere antibody, biological marker of the CREST syndrome as distinct from scleroderma].

Abstract

Using HEp2 cells to study antinuclear antibodies has resulted in the discovery of the anti-centromere antibody which is thought to separate the CREST syndrome from progressive systemic sclerosis (scleroderma). This antibody seems to be exceptional in healthy subjects and are in patients with connective tissue diseases, except for scleroderma. It has also been found in CREST syndrome associated with other diseases, such as primary cirrhosis and neoplasias. In our study, the sensitivity of the anti-centromere antibody was 89.1% and its specificity 92.3% which shows that it is worth looking for.

• Authors: A M Rouquette-Gally, M H Stern, A C Prost, N Abuaf, J C Homberg, A Combrisson
• Journal: Presse medicale (Paris, France : 1983) (Presse Med) 1985 Jul 13-20 Vol. 14 Issue 28 Pg. 1497-500 ISSN: 0755-4982 [Print] France
• Vernacular Title: L'anticorps anticentromère, marqueur biologique de la variété CREST de la sclérodermie.
• PMID: 2931679 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antibodies, Antinuclear

Topics

• Adult
• Aged
• Animals
• Antibodies, Antinuclear (analysis)
• Calcinosis (immunology)
• Centromere (immunology)
• Chromosomes (immunology)
• Connective Tissue Diseases (immunology)
• Diagnosis, Differential
• Female
• Fingers
• Humans
• Male
• Middle Aged
• Rats
• Raynaud Disease (immunology)
• Scleroderma, Systemic (immunology)
• Syndrome
• Telangiectasis (immunology)